Saturday, July 11, 2026

Drug profile · INN

reuteri

reuteri is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 2
Pipeline programs 0
News articles 0
Drug details — reuteri
Class
Route
Patents
2
Programs
0
Data quality
0.70

Quick answer

reuteri is an FDA-listed pharmaceutical active ingredient.

Key facts

INN reuteri

Approval history

Authority Status Date
NMPA clinical trials

Related patents

  1. US 12180463

    Lactobacillus reuteri

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 10968495

    Lactobacillus reuteri and use thereof

    Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is reuteri?

reuteri is an FDA-listed pharmaceutical active ingredient.